BASF SE, Ludwigshafen, Germany.
BASF SE, Ludwigshafen, Germany.
Regul Toxicol Pharmacol. 2019 Nov;108:104442. doi: 10.1016/j.yrtph.2019.104442. Epub 2019 Aug 14.
Read-across and grouping is one of the most commonly used alternative approaches for data gap filling in registrations submitted under the REACH Regulation as defined by the European Chemicals Agency (ECHA) in their 'Read-Across Assessment Framework' (RAAF, 2017). At the same time, the application of read-across is rejected by ECHA frequently due to various reasons. As a major reason hereof, applicants fail to reduce the level of 'remaining uncertainty' intrinsical to every read-across approach compared to testing a substance experimentally. Recently, the use of metabolomics to support read-across cases with biological information has been reported in a case study with phenoxy herbicides (Ravenzwaay et al., 2016). In the present case-study a 'weight-of-evidence' read-across approach from 2-aminoethanol (MEA = 'source') to 3-aminopropanol (3AP = 'target') with metabolomics as 'supporting evidence' reducing the remaining uncertainties is reported. We demonstrate the high structural similarity of the two analogous substances based on the available data and we report how metabolome data add confidence concerning mechanistic similarity in this read-across approach. Finally, the herein described read-across case supported by metabolomics is used to cover the data gaps in repeated dose and reproductive toxicity endpoint of 3AP via weight of evidence for the REACH-registration.
阅读跨距和分组是在 REACH 法规下提交注册申请时填补数据空白最常用的替代方法之一,这是欧洲化学品管理局(ECHA)在其“阅读跨距评估框架”(RAAF,2017)中定义的。与此同时,ECHA 经常因各种原因拒绝使用阅读跨距。其中一个主要原因是,与实验测试物质相比,申请人未能降低每种阅读跨距方法固有的“剩余不确定性”水平。最近,代谢组学在使用生物信息支持阅读跨距案例方面的应用在一项苯氧除草剂案例研究中得到了报道(Ravenzwaay 等人,2016)。在本案例研究中,我们报告了一种“证据权重”阅读跨距方法,从 2-氨基乙醇(MEA=“源”)到 3-氨基丙醇(3AP=“靶”),并使用代谢组学作为“支持证据”来降低剩余不确定性。我们根据现有数据证明了这两种类似物质的高度结构相似性,并报告了代谢组学数据如何在这种阅读跨距方法中增加关于机制相似性的可信度。最后,本文描述的通过代谢组学支持的阅读跨距案例用于通过证据权重覆盖 3AP 的重复剂量和生殖毒性终点的数据空白,以满足 REACH 注册的要求。